Clinical trial

Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency

NCT07361263

Study summary

ClinicalTrials.gov

Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record estradiol valerate Normalized identity: estradiol valerate View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention esthinylestradiol Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-09

PhaseNA

Conditions

AVP Deficiencyverified · MONDO: neurohypophyseal diabetes insipidus

Diabetes Insipidusverified · MONDO: diabetes insipidus

Interventions

estradiol valerateDRUG · verified · RxNorm: estradiol valerate

esthinylestradiolDRUG

Sponsors & collaborators

University Hospital, Basel, Switzerlandlead sponsor

Mapped research locations

BaselSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07361263 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.